Add like
Add dislike
Add to saved papers

The efficacy and tolerability of 40% Pyruvic acid on acne vulgaris, post acne scar and hyperpigmentation in Indians.

INTRODUCTION: Pyruvic acid in concentration between 40% and 70% is currently been used as a superficial to medium peeling agent for various dermatological indications including acne . However, there is a paucity of its efficacy studies on acne in Asians, particularly in Indian skin.

AIM: Our study was aimed at determining the efficacy and tolerability of 40% pyruvic acid on acne, post acne hyperpigmentation and scarring.

MATERIALS AND METHODS: A total of 30 patients with active acne, post acne scarring and hyperpigmentation were included. Patients already on oral antibiotic or topical antiacne medication for the last 4 weeks, a history of hypertrophic scarring, keloids, active or recurrent herpes were excluded. Chemical peeling was done at 2 weekly interval from 0 to 12 weeks. An objective assessment of active acne lesions, post-acne scarring, and hyperpigmentation were made at each visit that is at 0, 4,8,12 and 24 weeks. Patients were followed up 2 weeks after the last peel and again at 24 weeks. Permission from the ethical committee was also obtained.

RESULTS: There was significant decrease in the number of comedones at 12 weeks compared to 0 week ( P=0.001). Similarly the number of papules decreased from o weeks to 12 weeks (P value 0.004). Acne score improved from 0 weeks to 12 weeks ( P <0.0001); from 0 weeks to 24 weeks(P = 0.011) and hyperpigmentation improved from 0 weeks to 12 weeks (P=0.008); from 0 weeks to 24 weeks (P=0.021).

CONCLUSION: Our study showed a significant decrease in comedones, papules, acne score and hyperpigmentation, though acne scar did not improve significantly. However a study with larger sample is needed due to the limited number of patient population in our study.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app